Gmax
Gmax is a biopharmaceutical company that develops and commercializes antibody therapeutics for the treatment of cancer and metabolic disorders.
Business Model:
Revenue: $10.2M
Employees: 11-50
Industries / Tags:
Detailed Gmax Information
Geographic Data
Address: 288 Qiuyi Road
City: Hangzhou
State: zhejiang province
Zip: 310052
Country: CN
Financial Info
Stage:
series c
Raised Last:
$78M
Raised Total:$78M
Social
Metrics
4,676,052Website Global Rank
2,081Website Monthly Traffic
Twitter Followers
Description
Gmax is a biopharmaceutical company that develops and commercializes antibody therapeutics for the treatment of cancer and metabolic disorders.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2017 | Series B | - | 3/2021 | Series C | 4 | $78M |
Brill Capital China Merchants Group Cowin Capital Tigermed Brill Capital China Merchants Group Cowin Capital Tigermed |
12/2014 | Series A | $7M | 6/2017 | Series B | - |
YF Capital YF Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
